ZURA insider trading

NasdaqCM Healthcare

Zura Bio Ltd — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
31
Last 90 days
8
Buys / sells
23% / 13%
Market cap
$641.39M

About Zura Bio Ltd

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.

Company website: zurabio.com

ZURA insider activity at a glance

FilingIQ has scored 31 insider transactions for ZURA since Mar 20, 2023. The most recent filing in our index is dated Apr 1, 2026.

Across the full history, 7 open-market purchases and 4 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ZURA insider trades is 58.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

13F funds holding ZURA

Frequently asked

How many insider trades does FilingIQ track for ZURA?
FilingIQ tracks 31 Form 4 insider transactions for ZURA (Zura Bio Ltd), covering filings from Mar 20, 2023 onwards. 8 of those were filed in the last 90 days.
Are ZURA insiders net buyers or net sellers?
Across the full Form 4 history for ZURA, 7 transactions (23%) were open-market purchases and 4 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ZURA insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ZURA in?
Zura Bio Ltd (ZURA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $641.39M.

Methodology & sources

Every ZURA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.